Latest News

  • MIT Ultrasound Sticker Continuously Monitors Deep Organs for 48 Hours

    Diagnostics World News | An MIT engineering team invented a new ultrasound sticker, enabling continuous high-resolution imaging for up to 48 hours.

    Aug 18, 2022
  • Lab Network Could Help Expand Access To Saliva-Based Testing

    Diagnostics World News | A Yale-based diagnostics initiative is building a nationwide network of clinical laboratories embracing an open-source testing protocol for COVID-19 using saliva. Ultimately, the labs could become important players in public health responses to pandemics of the future and, perhaps more immediately, the ongoing monkeypox outbreak.

    Aug 17, 2022
  • Long COVID and Chronic Fatigue Syndrome Have A Lot In Common

    Diagnostics World News | Evidence is emerging that long COVID (formally “post-acute sequelae SARS-CoV-2 infection,” or PASC) bears a striking, molecular-level resemblance to the disabling and complex illness now known as myalgic encephalomyelitis/chronic fatigue syndrome.

    Aug 16, 2022
  • Contact Lenses Get Smart: Emerging Eye-Based Tools Look to Monitor Health, Diagnose Disease, and Treat Various Conditions

    Diagnostics World News | Contact lenses may have first arrived to help correct vision impairments, but new tech advances are transforming this familiar product into a tool capable of far more.

    Aug 11, 2022
  • GA4GH Phenopackets Standard Published By ISO

    Diagnostics World News | The International Organization for Standardization (ISO) has published Phenopackets, a standard initially developed by the Global Alliance for Genomics and Health and championed at ISO under the Canadian Mirror Committee to ISO/TC215/SC1 Genomics informatics, and supported by the Standards Council of Canada.

    Aug 10, 2022
  • Online ‘Biclustering’ Tool Stratifies Patients To The Molecular Level

    Diagnostics World News | Researchers in Germany have developed a web-based tool, powered by machine learning, which extracts disease subtypes from large pools of patient data. The goal is more precise and robust predictions about molecular signatures that can serve as a starting point for investigating disease heterogeneity.

    Aug 9, 2022
  • NIST Develops Monkeypox Reference Materials, Sees Growing Role in Outbreak Response

    Diagnostics World News | The National Institute of Standards and Technology has produced a reference material for use as a positive control when developing monkeypox diagnostic tests. The reference material marks the success of a proof-of-concept test and marks a shift in thinking at NIST since the COVID-19 pandemic.

    Aug 4, 2022
  • Electrical Tissue Dissociation Speeds Time to Single Cell Sequencing, Diagnosis

    Diagnostics World News | A team of researchers from Brown University are in the process of developing a simple, inexpensive, portable device to electrically dissociate tissues into viable single cells. They’ve published the work in Scientific Reports, and foresee the approach being useful in both clinical diagnostics and basic scientific research.

    Aug 2, 2022
  • PerkinElmer Divests Name, Non-Life Sciences, Diagnostics Businesses

    Diagnostics World News | PerkinElmer announced this morning its intent to divest its Applied, Food, and Enterprise businesses through an agreement with New Mountain Capital. At the close of the deal, expected in the first quarter of 2023, the Analytical and Enterprise Solutions business will likely retain the PerkinElmer name and brand. The Life Sciences and Diagnostics business will be rebranded.

    Aug 1, 2022
  • C-Reactive Protein Test for Inflammation, NGS-Based Cancer Testing, More

    Diagnostics World News | A pioneering low-cost device captures three-dimensional images for eye screening; exceptionally sensitive hybridization capture-based technology integrates into diagnostic exams; a new institute plans to develop at least ten new drugs or diagnostic approaches for heart and lung disease within five years; and more.

    Jul 28, 2022
  • Follow the Money: Direct-to-Consumer Genetic Testing, Long COVID Detection, More

    Diagnostics World News | Funding for innovative genetic risk and disposition score analyses, whole-genome sequencing, a centralized patient data network, and more.

    Jul 27, 2022
  • Self-Testing: ‘With Crisis Comes Opportunity’

    Diagnostics World News | The COVID-19 pandemic is ushering in an era of self-testing that has been at least a decade in the making. Despite the evidence, it took a public health crisis to finally convince most clinicians that the benefits of self-swabbing with an at-home test kit outweigh any of the potential problems. Before long, multiple studies emerged showing patients did just as well as clinicians with rapid self-testing whether observed or unobserved.

    Jul 21, 2022
  • Nanopore-Based DNA Computing Detects Cancer at Subfemtomolar Concentrations

    Diagnostics World News | Bile duct cancer is a complex and rapidly progressing disease often deemed terminal at the time of diagnosis. However, a research team at the Tokyo University of Agriculture and Technology discovered nanopore-based DNA computing technology as a means of early cancer detection and improved patient outcomes.

    Jul 20, 2022
  • Evolving Regulatory Landscape For Companion Diagnostics

    Diagnostics World News | It is now the expectation if not the reality that companion diagnostics (CDx) be approved concurrently with their corresponding therapeutic product. Multiple countries are quickly adopting policies and regulations for drug-diagnostic co-development and common themes are emerging about how a CDx should be clinically validated. At the upcoming Next Generation Dx Summit, speakers will explore the evolving global regulatory landscape for diagnostics and the impacts on co-development programs, as well as strategies for navigating the changing environment.

    Jul 19, 2022
  • Consumers Have A Love-Hate Relationship With Smart Gadgets

    Diagnostics World News | Consumers frequently express a mixed bag of sentiments about fitness wearables and body-monitoring devices flooding the market. Diagnostics World News recently surveyed a handful of users of wearables and body-monitoring devices to get firsthand feedback on the data, the user experience, and their concerns.

    Jul 14, 2022
  • Blood Biomarker Could Help Predict Severe Crohn’s Disease, Enable Early Intervention

    Diagnostics World News | An international group of researchers has shown that a biomarker may help predict complicated Crohn’s disease and can be detected long before diagnosis.

    Jul 12, 2022
  • Novel ct-DNA Blood Test Safely Spares Colon Cancer Patients from Chemotherapy

    Diagnostics World News | Australian-American researchers showcase a new ct-DNA diagnostic blood test that reduces the need for adjuvant chemotherapy without increasing colon cancer recurrence rates.

    Jul 7, 2022
  • DNA Methylation Making Its Mark In Early Cancer Detection

    Diagnostics World News | The current status in the development of DNA methylation biomarkers is a topic of several liquid biopsy talks at the upcoming Next Generation Dx Summit.

    Jul 6, 2022
  • A Look Ahead at Pan-Cancer Testing: Big Unknowns, Great Debates, and Key Questions Facing the Future of the Field

    Diagnostics World News | In recent months, Diagnostics World has explored the realm of pan-cancer testing.  As research and development continue in efforts to build upon the progress made so far, there’s still plenty to be sorted out. Here we dig a bit deeper into some of the biggest lingering issues facing the future of this fledgling field.

    Jul 5, 2022
  • NGS Solution Detects Aneuploidies, AI-Powered Biomarker Test for Urothelial Cancer, More

    Diagnostics World News | A blood test detects T cells activated by Borrelia burgdorferi, the bacterium that causes Lyme disease; a new artificial intelligence model accurately identifies patients at increased risk of undiagnosed structural heart disease; newborn screening for sickle cell disease expands in sub-Saharan Africa; a new melanoma test accurately assesses and classifies advanced melanoma patients as likely or unlikely to benefit from immune checkpoint inhibitor therapies; and more.

    Jun 30, 2022